|
Biopharma raising $500K eyes competitive asthma/COPD drug market
MedCity News A biopharmaceutical startup developing a new treatment for asthma that targets the nitric oxide signaling system has raised $50000 of a planned $500000 fundraise, according to recently filed SEC documents. SAJE Pharma LLC's lead compound appears to … |
View full post on asthma – Google News